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sychiatryArchival Report BPCortical Thickness in Individuals at High Familial
Risk of Mood Disorders as They Develop Major
Depressive Disorder
Martina Papmeyer, Stephen Giles, Jessica E. Sussmann, Shauna Kielty, Tiffany Stewart,
Stephen M. Lawrie, Heather C. Whalley, and Andrew M. McIntoshABSTRACT
BACKGROUND: Frontal and temporal cortical thickness abnormalities have been observed in mood disorders.
However, it is unknown whether cortical thickness abnormalities reflect early adverse effects of genetic and
environmental risk factors predisposing to mood disorders or emerge at illness onset.
METHODS: Magnetic resonance imaging was conducted at baseline and after a 2-year follow-up interval in 111
initially unaffected young adults at high familial risk of mood disorders and 93 healthy control subjects (HC). During
the follow-up period, 20 high-risk subjects developed major depressive disorder (HR-MDD), with the remainder
remaining well (HR-well). Cortical surface reconstruction was applied to measure cortical thickness of frontal and
temporal regions of interest. Mixed-effects models were used to investigate differences and longitudinal changes in
cortical thickness.
RESULTS: Reduced cortical thickness in the right parahippocampal and fusiform gyrus across both time points was
found in both high-risk groups. HR-MDD also had thinner parahippocampi than HR-well individuals. Over time,
HR-well and HC individuals had progressive thickness reductions in the left inferior frontal and precentral gyrus,
which were greater in HR-well subjects. HR-MDD showed left inferior frontal gyrus thickening relative to HR-well
subjects and left precentral gyrus thickening relative to HR-well and HC individuals.
CONCLUSIONS: Reduced right parahippocampal and fusiform gyrus thickness are familial trait markers for
vulnerability to mood disorders. Increased risk for mood disorders is associated with progressive cortical thinning
in the left inferior frontal and precentral gyri in subjects who remain well. In contrast, onset of depression is
associated with increasing left inferior frontal and precentral thickness.


















78Mood disorders including bipolar disorder (BD) and major
depressive disorder (MDD) are among the most common mental
disorders and a leading cause of disability worldwide (1). First-
degree relatives of BD patients have a tenfold excess risk of
BD compared with the general population and a threefold
increased risk of MDD (2). The aggregation of mood disorders
within families together with moderate to high heritability
estimates and evidence of a shared genetic architecture
provide strong support for overlapping causal pathways in
BD and MDD (3–6).
Accumulating evidence from structural magnetic resonance
imaging (MRI) studies indicates that neuroanatomical changes
in frontal and temporal lobes are associated with mood
disorders (7–10). Volumetric gray matter reductions of the
prefrontal lobe have been consistently found in MDD and BD,
predominantly in the orbitofrontal gyrus (8,11) and anterior
cingulate cortex (10,12) but also in the inferior (10,12), middle
(10,13), and superior frontal gyrus (10,14). Furthermore, grayN: 0006-3223
SEE COMMENTAmatter decreases have been observed in the precentral gyrus
(10,13), superior temporal gyrus (15,16), and medial temporal
lobe, particularly in the parahippocampal gyrus (10,17).
Gray matter volume is a composite of cortical thickness and
surface area, and research suggests that gray matter volume
is more closely linked to surface area than to thickness (18).
Cortical surface area and thickness are also genetically and
phenotypically independent (18), but the contribution of cort-
ical thickness toward structural brain abnormalities in mood
disorders remains largely unknown. A small number of studies
have, however, reported cortical thickness abnormalities in
MDD and BD patients in the frontal lobe (19–31) and superior
temporal gyrus (22,23,29,31). Moreover, thickness reductions
in the inferior and middle temporal (31), parahippocampal (22),
and fusiform gyrus (21,23) have been found in BD.
Prefrontal brain regions are closely involved in emotion
processing and affect regulation—functions clearly disturbed
in mood disorders (32,33). Distinct frontal lobe structures79
80
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Cortical Thickness in High Risk of Mood Disorders
Biological
Psychiatrymaintain reciprocal connections to temporal brain areas and
are intensively interconnected with limbic regions. Accord-
ingly, it has been postulated that a medial prefrontal network,
highly connected to superior and medial temporal lobe, is
centrally involved in mood disorders (34,35).
Most imaging studies of mood disorders have assessed
brain structure in affected individuals. These studies cannot
discern whether structural brain abnormalities reflect early
neurodevelopmental disruptions predisposing to illness,
events linked to illness onset, or whether they are adaptive
or secondary to the effects of chronic illness or its treatment.
Neuroimaging studies of individuals at high risk of mood
disorders because of a close family history of BD hold the
potential to identify structural brain abnormalities related to
enhanced familial vulnerability, unconfounded by the presence
of illness and medication. However, to the best of our knowl-
edge, no study has yet examined the effects of familial risk on
cortical thickness in a prospective longitudinal study.
The Bipolar Family Study is designed to examine the timing
of structural brain abnormalities in mood disorders and their
relationship to familial risk and onset of illness. Based on the
above literature, we compared cortical thickness of frontal and
temporal regions of interest (ROI) over a 2-year time interval
between three groups: high-risk of mood disorders individuals
who were well at baseline but developed MDD during
the follow-up period (HR-MDD), high-risk individuals who
remained well over the same time period (HR-well), and
unaffected healthy control subjects (HC). We hypothesized
that frontotemporal cortical thickness reductions related to
familial risk of mood disorders are present before the onset of
illness. Furthermore, we hypothesized that these regions
reduce in thickness progressively in the 2-year period before
illness and that an onset of MDD is associated with more
pronounced thickness reductions as compared with individu-
als who remain well.
METHODS AND MATERIALS
Participants
Participants were recruited as part of the Bipolar Family Study
(36). High-risk of mood disorder individuals because of a close
family history of BD were identified via affected relatives
(Supplement 1). Unaffected, unrelated control subjects with
no personal or family history of BD were identified from the
social contacts of the high-risk subjects and group-matched
for age, sex, and premorbid intelligence estimated with the
National Adult Reading Test (37). Comparison subjects were
screened for Axis I disorders using the Structured Clinical
Interview for DSM-IV Axis I Disorders.
At baseline, exclusion criteria for all study groups included a
personal history of MDD, mania or hypomania, psychosis, or
any major neurological or psychiatric disorder; substance
dependence; learning disability; head injury that included loss
of consciousness; and any contraindications to MRI.
Approximately 2 years after the initial baseline examination,
all participants were invited for a follow-up assessment.
Written informed consent was acquired from all subjects and
the study was approved by the Research Ethics Committee for
Scotland.2 Biological Psychiatry ]]], 2014; ]:]]]–]]] www.sobp.org/journalClinical Assessment
Clinical assessments were conducted at the time of the first
and second MRI scans. The mean interval in years between
assessments was 2.13 (SD .22), 2.15 (SD .22), and 2.10 (SD
.13) for the HC, HR-well, and HR-MDD groups, respectively.
The diagnostic status of consenting subjects not returning for
a second assessment was determined through written contact
with the National Health Service. Clinical interviews were
conducted by experienced psychiatrists (A.M.M., J.E.S.).
Based on the follow-up clinical examination or information
from case notes, high-risk subjects were grouped into those
who remained well (HR-well) and those who subsequently
developed MDD (HR-MDD). At both assessments, current
manic and depressive symptoms were rated using the Young
Mania Rating Scale (38) and Hamilton Depression Rating Scale
(HAM-D) (39).
Statistical analyses of demographic and clinical data were
conducted using one-way analyses of variance (ANOVAs),
chi-squares tests, or Kruskal-Wallis tests where appropriate
in SPSS version 19 (http://www.spss.com).
Magnetic Resonance Imaging Acquisition
Imaging at baseline and follow-up assessment were carried
out at the Brain Imaging Research Centre for Scotland on a GE
1.5 T Signa scanner (GE Medical, Milwaukee, Wisconsin).
The T1 sequence was a coronal gradient echo sequence
with magnetization preparation (magnetization prepared
rapid acquisition gradient-echo) and yielded 180 contiguous
1.2 mm coronal slices (inversion time 5 500 msec; echo time 5
4 msec; matrix 5 192 3 192; flip angle 5 81).
Cortical Thickness Measurement
The acquired T1 images were processed using the surface-
based stream in FreeSurfer version 5.1.0 (http://surfer.nmr.
mgh.harvard.edu/fswiki/recon-all/) (40,41), fully described in
Supplement 1.
The following ROIs were selected for each hemisphere
(Figure 1): anterior cingulate cortex (rostral and caudal anterior
cingulate cortex), frontal pole, inferior frontal gyrus (pars
opercularis, triangularis, and orbitalis), middle frontal gyrus
(rostral and caudal middle frontal gyrus), superior frontal gyrus,
orbitofrontal gyrus (lateral and medial orbitofrontal gyrus),
precentral gyrus, superior temporal gyrus, parahippocampal
gyrus, and fusiform gyrus.
Statistical Analyses
All statistical analyses were computed in SPSS version 19,
except for the false discovery rate (FDR) corrections (42),
which were conducted in R version 2.13.0 (http://www.r-
project.org), using the p.adjust(BH) function of the stats package.
Given the longitudinal study design and the fact that the
data consist of nonuniform numbers of repeated measure-
ments, we performed linear mixed-effects models to inves-
tigate structural brain differences for each ROI over time.
Linear mixed-effects modeling has several advantages over
the commonly applied repeated-measures ANOVA, as case-
wise deletion of missing data is not necessary, which allows

























































































































Figure 1. Cortical regions of
interest.
Cortical Thickness in High Risk of Mood Disorders
Biological
Psychiatrycorrelation structures of repeated measurements nested within
participants. In the linear mixed-effects model used, the
intercept term is treated as a random effect that varies by
individual so that intraindividual correlation among the struc-
tural brain measures of a particular individual is taken into
account. The following independent variables were used as
predictors of cortical thickness for the different ROIs: group,
time (baseline versus follow-up assessment), and group-by-
time interaction. Age and sex served as covariates. Accord-
ingly, significant group effects represent differences in cortical
thickness between the groups across both time points. Time
effects represent differences in cortical thickness between
baseline and follow-up examination. Group-by-time interac-
tions represent differences in cortical thickness development
over time between groups.
A statistical significance level of pFDR # .05 was chosen,
fully corrected for multiple comparisons using the Benjamini
and Hochberg FDR procedure (42). Wherever significant
between-group differences were found, pairwise comparisons
were performed between the three groups for which p values
were corrected according to Tukey’s honest significance
difference (HSD) method (pHSD # .05). For significant inter-
action effects, subsequent pairwise comparisons were per-
formed with p values being adjusted according to Bonferroni
procedure (pBonf # .05).
Wherever significant between-group differences were found
in the longitudinal analysis, an additional analysis of cova-
riance was conducted between the groups for cortical thick-
ness of the ROI at baseline, adjusted for age and sex. This
analysis was intended to assess whether the observed
longitudinal ROI abnormalities were also predictive at baseline
for an onset of MDD.
To assess the relationship between severity of depressive
symptoms and cortical thickness, we calculated the Spearman
correlation coefficient between the HAM-D total score and the
ROIs for each group. In each case, p values were corrected
using the FDR procedure and considered significant when
pFDR # .05.
To examine potentially confounding effects of exposure to
medication and relatedness of subjects on cortical thickness,
we performed the following additional analyses for significant
findings: we first repeated our analyses excluding medicated
HR-MDD subjects (n 5 4), followed by randomly excluding
related subjects (n 5 2 HC; n 5 17 HR-well; n 5 2 HR-MDD).RESULTS
Demographic and Clinical Measures
In total, 114 high-risk individuals provided suitable FreeSurfer
processed MRI data along with clinical information at baseline.
Of these, two individuals developed BD during the 2-year
follow-up period and were excluded from all analyses due to
the small sample size. Overall, 20 high-risk participants
received a diagnosis of MDD within the 2-year period, but
one individual had to be excluded from baseline analysis due
to unsatisfactory cortical parcellation of the MRI scan. Accord-
ingly, our analyses included 92 HR-well and 19 HR-MDD
subjects at baseline. Of the HC individuals, 96 provided
suitable MRI data along with clinical information at baseline.
Three developed MDD in the follow-up period and were
therefore excluded from all analyses, leading to a sample size
of 93 HC subjects. At follow-up, 63 HR-well, 20 HR-MDD, and
62 HC subjects provided suitable data. Four HR-MDD parti-
cipants were prescribed antidepressant medication at follow-
up. Three subjects were taking selective serotonin reuptake
inhibitors (1 fluoxetine, 1 citalopram, 1 sertraline) and one
participant was on a tricyclic antidepressant (lofepramine). The
remaining 16 HR-MDD subjects were unmedicated.
There were no significant differences between the groups in
terms of age, gender, handedness, verbal intelligence, and
Young Mania Rating Scale sum score at any assessment point
(Table 1). There were, however, significant group differences at
baseline (p # .007) and follow-up (p # .023) for clinical
measures of depression from the HAM-D. At baseline, HR-
well and HR-MDD subjects had significantly higher depression
scores (p # .047 and p # .003, respectively) than HC
individuals, with no significant differences between the high-
risk groups. At follow-up, HR-MDD subjects had higher
depression scores than HC and HR-well individuals (p #
.013 and p # .010, respectively), as expected, with no
significant differences between HC and HR-well individuals.
Cortical Thickness
Table 2 and Figure 2 depict the results of our linear mixed-
effects model analyses. A significant group effect (pFDR # .05)
was found for the right parahippocampal gyrus (p # .002) and
right fusiform gyrus (p # .005). Post hoc analyses revealed





































































































(n 5 20) Statistics
Mean (SD) Mean (SD) Mean (SD) F/χ2 p Mean (SD) Mean (SD) Mean (SD) F/χ2 p
Age (Years) 21.01 (2.45) 21.20 (2.88) 21.10 (2.82) .13 .88 22.82 (2.73) 23.71 (2.84) 23.33 (2.98) 1.77 .17
Gender (M:F) 40:53 44:48 9:10 .46 .80 21:41 29:34 7:13 2.12 .35
Handedness (Right:Other) 88:5 81:11 19:0 5.54 .24 61:1 57:6 20:0 5.43 .07
NART IQ 110.31 (8.00) 108.39 (9.37) 107.26 (6.80) 1.64 .20 – – – – –
ISI (Months) 2.13 (.22) 2.15 (.22) 2.10 (0.13) .20 .82 – – – – –
HAM-Da 0 (1) 0 (2) 1 (5) 9.79 .01 1 (3) 1 (2) 5 (12) 7.59 .02
YMRSa 0 (0) 0 (0) 0 (0) 3.48 .18 0 (0) 0 (1) 0 (0) .79 .68
Bold indicates significant effect.
F, female; HAM-D, Hamilton Depression Rating Scale; HC, unaffected healthy control subjects; HR, high risk; HR-MDD, individuals at high risk
for mood disorders who were well at baseline but developed major depressive disorder during the follow-up period; HR-well, individuals at high risk
for mood disorders who were well at baseline and remained well during the follow-up period; ISI, interscan interval; M, male; MDD, major depressive
disorder; NART, National Adult Reading Test; YMRS, Young Mania Rating Scale.
aKruskal-Wallis test, median and interquartile presented for skewed variables.
Cortical Thickness in High Risk of Mood Disorders
Biological
Psychiatryindividuals have reduced parahippocampal thickness across
time as compared with HC subjects. This brain region was, on
average, 4.00% thinner in the HR-well and 10.89% thinner in
the HR-MDD group relative to control subjects across both
time points. Moreover, HR-MDD subjects displayed more
pronounced thickness reductions in this region as comparedTable 2. Longitudinal Analysis of Cortical Thickness
HC HR-well
Baseline Follow-up Baseline Follow-up Ba
Region (Gyrus) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Me
L Inf Frontal G 2.47 (.22) 2.44 (.17) 2.49 (.15) 2.40 (.17) 2.5
R Inf Frontal G 2.46 (.17) 2.44 (.19) 2.42 (.15) 2.42 (.17) 2.5
L Mid Frontal G 2.38 (.18) 2.39 (.16) 2.42 (.16) 2.39 (.17) 2.4
R Mid Frontal G 2.35 (.16) 2.33 (.17) 2.34 (.14) 2.34 (.16) 2.3
L Sup Frontal G 2.70 (.18) 2.69 (.19) 2.70 (.18) 2.68 (.18) 2.7
R Sup Frontal G 2.65 (.19) 2.61 (.17) 2.64 (.19) 2.61 (.18) 2.7
L Orbitofrontal G 2.44 (.23) 2.39 (.20) 2.45 (.20) 2.41 (.17) 2.4
R Orbitofrontal G 2.41 (.23) 2.39 (.20) 2.38 (.19) 2.38 (.19) 2.4
L Frontal Pole 2.95 (.40) 2.95 (.41) 3.03 (.43) 3.03 (.38) 3.0
R Frontal Pole 2.90 (.41) 2.87 (.40) 2.84 (.36) 2.85 (.31) 3.0
L Ant Cingulate 2.48 (.33) 2.46 (.29) 2.47 (.32) 2.44 (.28) 2.4
R Ant Cingulate 2.39 (.31) 2.37 (.26) 2.43 (.32) 2.35 (.29) 2.4
L Precentral G 2.49 (.14) 2.45 (.13) 2.49 (.13) 2.43 (.15) 2.4
R Precentral G 2.45 (.12) 2.43 (.14) 2.44 (.13) 2.42 (.15) 2.4
L Fusiform G 2.33 (.21) 2.29 (.18) 2.32 (.18) 2.27 (.18) 2.2
R Fusiform G 2.37 (.18) 2.38 (.17) 2.31 (.22) 2.33 (.19) 2.2
L Sup Temporal G 2.42 (.22) 2.43 (.21) 2.45 (.19) 2.41 (.20) 2.4
R Sup Temporal G 2.44 (.19) 2.50 (.18) 2.42 (.21) 2.433 (.21) 2.4
L Parahippoc G 2.24 (.34) 2.25 (.32) 2.19 (.34) 2.12 (.37) 2.1
R Parahippoc G 2.23 (.34) 2.27 (.29) 2.15 (.35) 2.17 (.31) 1.9
Bold indicates significant effect after false discovery rate correction.
G, gyrus; HC, unaffected healthy control subjects; HR, high risk; HR-MD
but developed major depressive disorder during the follow-up period; HR-w
and remained well during the follow-up period; inf, inferior; L, left; MDD, ma
right; sup, superior.
4 Biological Psychiatry ]]], 2014; ]:]]]–]]] www.sobp.org/journalwith the HR-well (pHSD # .041) group. For the right fusiform
gyrus, HR-well (pHSD # .028) and HR-MDD (pHSD # .014)
subjects have reduced cortical thickness as compared with
HC individuals, with no significant difference between the
high-risk groups. The fusiform gyrus was, on average, 2.11%


































seline Follow-up Group Effect Time Effect Group 3 Time
an (SD) Mean (SD) F p F p F p
2 (.20) 2.55 (.22) 3.14 .05 3.22 .08 5.35 ,.01
0 (.21) 2.45 (.18) 1.69 .19 3.51 .06 1.30 .28
3 (.19) 2.51 (.16) 3.41 .04 .93 .34 1.80 .15
9 (.20) 2.39 (.16) 1.54 .22 .57 .45 .47 .71
2 (.18) 2.81 (.20) 2.40 .10 .10 .76 1.04 .38
0 (.19) 2.74 (.17) 3.11 .05 .34 .56 1.65 .18
2 (.28) 2.48 (.20) .73 .48 .39 .54 2.66 .05
0 (.21) 2.42 (.19) .24 .79 .04 .85 .79 .50
6 (.38) 3.20 (.43) 3.00 .05 .73 .40 .44 .73
8 (.34) 3.06 (.44) 2.94 .02 .20 .66 .22 .88
8 (.33) 2.54 (.29) .22 .80 .00 1.00 1.57 .20
3 (.36) 2.42 (.23) .25 .78 1.88 .17 1.90 .13
8 (.18) 2.53 (.12) 2.10 .34 2.83 .10 8.67 ,.01
4 (.14) 2.46 (.16) .51 .60 2.02 .16 2.19 .09
9 (.21) 2.24 (.30) 1.04 .35 3.35 .07 1.72 .17
5 (.19) 2.29 (.23) 5.20 ,.01 .66 .42 .23 .88
5 (.18) 2.41 (.25) .04 .96 .98 .32 1.03 .38
0 (.18) 2.40 (.18) 3.60 .03 .50 .48 1.55 .21
4 (.37) 2.13 (.45) 1.76 .17 1.73 .19 1.43 .24
8 (.32) 2.03 (.37) 6.27 ,.01 .44 .51 .20 .90
D, individuals at high risk for mood disorders who were well at baseline
ell, individuals at high risk for mood disorders who were well at baseline

























































































































Figure 2. Significant group eff-
ects and group-by-time interac-
tions. Significant group-by-time int-
eractions were observed for the left
inferior frontal gyrus (A) and the left
precentral gyrus (B). Individuals at
high risk (HR) for mood disorders
who were well at baseline and
remained well during the follow-up
period (HR-well) showed more pro-
nounced thinning of both brain
regions as compared with the unaf-
fected healthy control subjects (HC)
over time, while the individuals at
high risk for mood disorders who
were well at baseline but developed
major depressive disorder (MDD)
during the follow-up period (HR-
MDD) showed cortical thickening
of these areas over time relative to
the HR-well subjects. The thicken-
ing of the left precentral gyrus in the
HR-MDD group was also signifi-
cantly distinct from the observed
thinning in the HC subjects. Signifi-
cant group effects across time were
observed for the right fusiform gyrus
(C) and the right parahippocampal
gyrus (D). HR-well and HR-MDD
subjects displayed reduced cortical
thickness in these regions relative to
HC across time, with the HR-MDD
group having more pronounced
right parahippocampal thinning than
the HR-well subjects.
Cortical Thickness in High Risk of Mood Disorders
Biological
Psychiatrygroup as compared with control subjects across both time
points.
A significant group-by-time interaction (pFDR # .05) was
detected for the left inferior frontal gyrus (p # .002) and the left
precentral gyrus (p # .001). For the inferior frontal region,
HR-well subjects had a greater cortical thickness decline
(3.61% thickness decline) relative to HC individuals (pBonf #
.002; 1.22% thickness decline) over time and exhibited a
distinct pattern of cortical thickness development as compared
with the HR-MDD group (pBonf # .002) that showed an
increasing thickening over time (1.19% thickness increase).
For the left precentral gyrus, HR-well subjects exhibited greater
cortical thickness decline (2.44% thickness decline) relative to
HC individuals (pBonf # .032; 1.61% thickness decline) over
time, while the HR-MDD group showed cortical thickness
expansions (2.02% thickness increase) over time, which was
in contrast to the regional thickness decline observed in HC
(pBonf # .001) and HR-well (pBonf # .001) subjects.
No significant effects of time were observed. Nominal
significant group effects and group-by-time interactions are
described in Supplement 1.
Prediction Analysis
To assess whether the observed longitudinal group effects for
the right parahippocampal and fusiform gyrus were also
predictive at baseline assessment for a subsequent onset of
MDD, additional analyses of covariance were performed for
cortical thickness of these ROIs at baseline (Table S1 inSupplement 1). There was a significant group effect for
right parahippocampal (p # .011) and right fusiform thickness
(p # .025). Post hoc pairwise tests indicated that the HR-MDD
group had reduced right parahippocampal thickness as com-
pared with HC participants (pBonf # .010), with no thickness
differences between the HC and HR-well group (pBonf # .251)
and only at the trend level between the two high-risk groups
(pBonf # .114). Post hoc tests for the right fusiform gyrus
revealed no significant pairwise group differences (pBonf #
.086 for HC versus HR-well; pBonf # .062 for HC versus
HR-MDD; pBonf # .559 for HR-well versus HR-MDD).
Correlation Analysis
There were no significant FDR-adjusted correlations between
the ROIs with depression severity as measured with the
HAM-D total score (Table S2 in Supplement 1).
Analysis of Potential Confounders
All results remained significant after FDR correction when ran-
domly excluding related subjects (Table S3 in Supplement 1).
For the right parahippocampus and fusiform gyrus, there was
a significant group effect (p # .002 and p # .009, respectively).
Significant group-by-time interactions were observed for the
left inferior frontal and precentral gyrus (p # .002 and
p # .001, respectively).
Moreover, all results remained significant when excluding
medicated subjects (Table S4 in Supplement 1). There was
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Psychiatry(p # .001) and fusiform gyrus (p # .009). Group-by-time
interactions for the left inferior frontal and precentral gyrus

























































This is, to the best of our knowledge, the first prospective
longitudinal study examining structural brain changes in
individuals at high risk of mood disorders who were unaffected
at initial assessment and either developed MDD or remained
well during the 2-year follow-up period. We report reduced
cortical thickness in the right parahippocampal and fusiform
gyrus across the two time points in both high-risk groups
relative to control subjects, with the HR-MDD group displaying
a thinner parahippocampus gyrus than the HR-well group.
Over time, HR-well subjects had progressive thickness reduc-
tions in the left inferior frontal and precentral gyrus relative to
control subjects, while the HR-MDD group showed cortical
thickening of these areas.
Our finding of a thinner parahippocampal and fusiform
gyrus in high-risk individuals suggests that thinning in these
temporal brain regions constitutes a familial trait marker for
vulnerability to mood disorders. Whether these structural brain
abnormalities are a consequence of shared genetic and/or
environmental effects cannot be determined from the data.
Given that they are already present in early adulthood, they are
unlikely to be of degenerative origin but likely represent
disturbances of normal brain development predisposing to
illness. Since the HR-MDD subjects displayed a thinner para-
hippocampal gyrus than the HR-well group over time, these
reductions may, in addition, be related to risk of developing
MDD. In line with this, our subsequent analyses revealed that
reduced parahippocampal thickness in the HR-MDD group
was already evident to some degree at baseline assessment
before onset of depression. This cross-sectional analysis
revealed group-level significance; however, subsequent pair-
wise comparisons indicated differences in parahippocampal
gyrus between the HR groups only at the trend level of
significance and therefore should be viewed as preliminary.
Previous studies support the possibility that right para-
hippocampal and fusiform thickness reductions are linked to
increased vulnerability for mood disorders. Right parahippo-
campal thinning has been associated with higher genetic
liability to BD (43), and research focusing on candidate genes
for mood disorders has detected associations between risk
allele carriers of the DISC1 or BDNF gene and reductions in
parahippocampal volume/thickness and fusiform volume
(44,45). Right parahippocampal thinning has been observed
in BD patients (22) and right fusiform thinning has been
observed in a BD cohort (21,23). The few studies investigating
cortical thickness in MDD have not detected similar findings
(20,24,25,27–30,46–48), but since they included predomi-
nantly medicated and/or older adults, it is likely that age,
medication, or duration of illness effects accounted for this
discrepancy. In keeping with this, a recent voxel-based
morphometry meta-analysis indeed showed that only first-
episode, mainly medication naïve MDD patients have
decreased gray matter in a cluster encompassing the right
parahippocampal gyrus (10). Longitudinal studies by Frodl
et al. (49,50) highlighted that hippocampal volume in MDD6 Biological Psychiatry ]]], 2014; ]:]]]–]]] www.sobp.org/journalpatients increased in response to a 3-year antidepressant
therapy and that relatively small hippocampal volumes were
found in nonremitted as compared with remitted patients.
Moreover, fusiform thinning in high-risk of depression individ-
uals because of a close family history of MDD has been found
to be associated with higher depression severity (51).
The parahippocampal gyrus is of particular interest for the
etiology of mood disorders because of its potential role in
emotional regulation. Functional MRI studies applying facial
affect processing paradigms found that BD and MDD patients
have increased activation in the right parahippocampus as
compared with control subjects (52). Our research group has
recently shown that individuals with a high risk of mood
disorders who are homozygous for risk haplotype of the
DGKH gene show relatively greater brain activation of the
right parahippocampus during a verbal fluency task as com-
pared with low-risk haplotype subjects, with the reverse
pattern being observed for healthy control subjects (53).
Furthermore, it has been shown that remitted depressed
patients maintain an increased connectivity of the posterior
cingulate cortex with the parahippocampal gyrus and that
greater connectivity appears to represent a prognostic factor
for future depressive episodes (54).
One plausible explanation for the right-lateralized findings
may be related to the possible dominance of the right hemi-
sphere in emotional processing [for a review, see (55)]. The
reduced cortical thickness in the parahippocampus and fusi-
form gyrus may thus be reflecting early right hemisphere-
specific brain development abnormalities in regions that are
playing a distinct role in emotional processing, thereby
increasing vulnerability for mood disorders.
Our analysis yielded significant group-by-time interactions
for the left inferior frontal and precentral gyrus. The finding of
abnormal thinning in these brain areas in the HR-well group
over time relative to control subjects suggests that thinning in
regionally specific left frontal lobe areas forms a familial trait
marker for vulnerability to mood disorders and that abnormal
thinning already takes place in early adulthood, potentially
reflecting early neurodegenerative processes.
Our results are in line with a twin study that found liability for
BD to be associated with inferior frontal and precentral gray
matter density reductions (56), with the precentral gray matter
reductions being limited to the right hemisphere. Despite
potential differences in underlying environmental and genetic
risk factors, cortical thinning in both of these frontal areas has
also been observed in a cohort of unaffected relatives of MDD
patients, with the inferior frontal thinning being restricted to the
right hemisphere (51). Also, reduced gray matter volumes of
the left precentral gyrus have been detected in individuals at
high risk of MDD because of negative cognitive styles (57).
Moreover, our findings are in concert with several neuro-
imaging studies reporting cortical thinning or gray matter
volume reductions in the circumscribed brain regions in BD
(12,19,22,23,31,58) and MDD patients (20,57).
Importantly, we observed a distinct pattern of increasing
relative cortical thickness over time in the HR-MDD as
compared with the HR-well group due to an absence of
regional thinning of the left inferior frontal and precentral gyrus
in the HR-MDD cohort. For the precentral gyrus, the cortical
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Psychiatrysignificantly different from the HC subjects. Since our results
remained significant after excluding medicated individuals, the
observed findings in the HR-MDD group cannot be attributed
to medication effects but rather appear to be linked to the
onset of illness and underlying disease-associated processes.
Given that human brain maturation involves frontal gray matter
loss beyond adolescence (59), the absence of cortical thinning
in the HR-MDD group may reflect a lack or delay of normal
synaptic pruning processes.
Although these findings are in contrast to the frequently
observed thinning or gray matter decrease in MDD patients,
they are in line with two of the three existing longitudinal
studies of MDD patients that found cortical thickening of
frontal or temporal brain structures over time (46,60) and with
recent findings of cortical thickening of various brain areas in
MDD patients (24,26,27,30). Interestingly, our findings overlap
with a longitudinal study of pediatric prodromal BD subjects,
displaying gray matter increases in the left ventrolateral
prefrontal cortex (including the inferior frontal gyrus) over time
as they convert to BD (61).
The strengths of this study are its longitudinal nature, the
assessment of subjects before illness onset, the relatively
young age of the participants, and the comparatively large
sample size of high-risk subjects and control subjects. In
addition, all subjects underwent careful clinical assessment at
both time points and the effects of medication and relatedness
of subjects were ruled out. All brain scans were obtained at the
same scanner using the identical protocol at both visits and
the MRI data were processed in an identical way using
thoroughly validated methods.
Nevertheless, some limitations need to be addressed. First,
it remains unknown whether currently unaffected HR-well
subjects may develop MDD in the future. Second, previous
longitudinal studies have reported that the majority of the high-
risk subjects who developed BD themselves experienced
depressive episodes years before conversion (62,63), so it
appears likely that some of our HR-MDD subjects may
develop BD in the future. The follow-up assessments of our
study cohort will clarify if some of the HR-MDD participants
will convert to BD and if some of our HR-well subjects will go
on to develop a mood disorder. Third, our study groups
differed with respect to depression symptom severity at
baseline. However, the median of the HAM-D total score
was only 1 in the HR-MDD group, suggesting only subsyn-
dromal depression symptoms. Moreover, our correlation anal-
ysis revealed no relationship between depression symptom
severity and our structural brain measures. Therefore, it
appears unlikely that general mood differences at baseline
between the groups have influenced our findings. Fourth, the
precise onset of MDD has not been assessed, so it remains
unknown if the duration of the depressive episode until the
second MRI scan was conducted might have influenced the
results.
In conclusion, our findings suggest that reduced cortical
thickness in right parahippocampal and right fusiform gyrus
across time constitutes a familial trait marker for vulnerability
to mood disorders. Moreover, enhanced liability to mood
disorders is associated with abnormal left inferior frontal and
precentral gyrus thinning in early adulthood, potentially reflect-
ing early neurodegenerative processes. By contrast, the onsetof MDD is linked to initially thickening of these brain areas,
possibly linked to disease-associated processes through a
lack of synaptic pruning. Although further longitudinal studies
are required to determine their validity, these findings advance
our understanding of the neuropathological processes under-
lying mood disorders. Future longitudinal studies should
particularly investigate the course of cortical thickness devel-
opment before and after the onset of depression using longer
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